Please login to the form below

Not currently logged in
Email:
Password:

pipelines

This page shows the latest pipelines news and features for those working in and with pharma, biotech and healthcare.

Pfizer’s Ibrance misses the mark in early breast cancer

Pfizer’s Ibrance misses the mark in early breast cancer

Given the continued breadth of our marketed portfolio and strength of our pipeline, our growth projections are not reliant upon any individual marketed medicine or pipeline opportunity,” he added.

Latest news

More from news
Approximately 14 fully matching, plus 1,865 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 162 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 182 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 43 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics